(Q36951734)

English

Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors

scientific article published on 28 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

object named as

Steven Joffe

14

0 references

Hillard M. Lazarus

8

object named as

Hillard M Lazarus

1 reference

Europe PubMed Central

17 August 2017

PMC publication ID

Stephanie J. Lee

9

object named as

Stephanie J Lee

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Theresa Hahn

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Philip L McCarthy

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Anna Hassebroek

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Christopher Bredeson

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

James L Gajewski

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Gregory A Hale

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Luis M Isola

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Charles F Lemaistre

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Fausto Loberiza

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Richard T Maziarz

12

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

J Douglas Rizzo

13

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Susan Parsons

15

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Navneet S Majhail

16

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

0 references

publication date

28 May 2013

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

31

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

19

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

2437-2449

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691359

9 September 2017

Reduced mortality after allogeneic hematopoietic-cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691359

9 September 2017

Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691359

9 September 2017

Efforts of the United States' National Marrow Donor Program and Registry to improve utilization and representation of minority donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691359

9 September 2017

Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691359

9 September 2017

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691359

9 September 2017

Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691359

9 September 2017

Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691359

4 September 2018

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691359

4 September 2018

Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691359

4 September 2018

Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23715573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23715573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313

1 reference

https://pubmed.ncbi.nlm.nih.gov/23715573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2012.46.6193

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36951734&oldid=1810776100"